Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model

J Microbiol Immunol Infect. 2019 Dec;52(6):911-919. doi: 10.1016/j.jmii.2019.03.002. Epub 2019 Mar 23.

Abstract

Background: Asthma is a heterogeneous inflammatory disorder of the airway. A Th2 response usually contributes to high levels of allergen-specific IgE and eosinophilic airway inflammation. Several findings have demonstrated that neutrophils, not eosinophils, are the major inflammatory cells in chronic asthma patients with steroid-resistance. Lactobacillus rhammosus GG (LGG) exhibits anti-inflammatory properties on OVA-induced acute airway inflammation.

Objective: We hypothesized that orally administrated LGG should reduce airway remodeling in chronic experimental models.

Methods: Female Balb/c mice were sensitized with OVA. LGG was used to investigate whether oral administrations of LGG inhibited OVA-induced airway inflammation in a chronic asthma model and the different intervention times between LGG pre-treatment and post-treatment groups. BALF was analyzed with Liu's stain and ELISA assay. Lung histopathology was assayed with HE, IHC and Masson's trichrome staining. Lung tissues were assayed with PCR (T-bet, GATA3, RORrt and Foxp3). Many cytokines were detected in the serum and BALF.

Results: LGG significantly decreased the number of infiltrating inflammatory cells. We also found that the oral LGG group suppressed not only Th2 cytokine, but also IL-17, TNF-α and HMGB1 in the BALF levels. However, GATA3 and RORrt decreased significantly in the RNA level in the LGG groups, but the T-bet and Foxp3 increased in the RNA level.

Conclusions: LGG not only had anti-inflammatory effects on OVA-induced airway inflammation, but also improved airway remodeling and collagen expression in the chronic asthma mouse model. Moreover, LGG might be an additional or supplementary therapy for allergic airway diseases.

Keywords: Airway remodeling; Asthma; Foxp3; LGG; RORrt.

MeSH terms

  • Administration, Oral
  • Airway Remodeling
  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Asthma / pathology*
  • Asthma / therapy
  • Bronchoalveolar Lavage Fluid / immunology
  • Cytokines / blood
  • Disease Models, Animal
  • Female
  • Inflammation / pathology
  • Lactobacillus rhamnosus / immunology*
  • Lung / microbiology*
  • Lung / pathology
  • Mice
  • Mice, Inbred BALB C
  • Th2 Cells / immunology

Substances

  • Anti-Inflammatory Agents
  • Cytokines